September 16, 2024

Supplemental Table S2 from Cost-Effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-Testing with hrHPV Genotyping for Cervical Cancer Screening

Los puntos clave no están disponibles para este artículo en este momento.

Supplemental Table S2 shows the distribution of patient attributes in the prevalent US population of women eligible for cervical cancer screening

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Harper et al. (Mon,) studied this question.

Preguntar a la IA

Me gusta

Guardar